Loading ...

Julia Goldstein

NIAID

https://ned.nih.gov/search/ViewDetails.aspx?NIHID=0011868809

Assessment Group

julia.goldstein@nih.gov

Work:

240-627-3509

Mobile:

Address:

NIAID

Committees:

,

Studies:

ITN005CT

-

Islet Transplantation for Type 1 Diabetes

ITN024ST

-

Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

ITN029ST

-

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

ITN030ST

-

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

ITN033AI

-

High Dose Immunosuppression and Autologous Stem Cell Transplantation for Multiple Sclerosis

ITN035AI

-

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis

ITN036ST

-

Renal Allograft Tolerance through Mixed Chimerism

ITN039ST

-

Research Study of ATG and Rituximab in Renal Transplantation

ITN040CT

-

Immunosuppressive Medications for Participants in ITN005CT

ITN054ST

-

BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

ITN056ST

-

Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation

ITN063ST

-

A Cohort Study of Operationally Tolerant Allograft Recipients

ITN073ST

-

Liver Transplantation with Tregs at MGH

ITN074ST

-

Liver Transplantation with Tregs at UCSF

ITN077AI

-

Best Available Therapy Vs. Autologous Hematopoietic Stem Cell Transplant For MS

ITN507ST

-

Study of Tolerant Kidney Transplant Recipients

ITN524ST-CTOT-12

-

Associating Renal Transplantation With the ITN Signature of Tolerance

ITN803ST

-

Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation (deLTa)

Bio:

Admin Links

Shortcuts

ITN Documents

Links